Results presented by AstraZeneca from its phase 3 trial of Imfinzi in patients with high-risk, non-muscle invasive bladder ...

Sanofi gained Rezurock in a $1.9 billion buyout of Kadmon in 2021, less than two months after the FDA approved the treatment ...

Amendment includes finalized cash amount and updated CVR terms for tender offer- LAVA announces new date for extraordinary general meeting of ...

Secretary of Health and Human ServicesRobert F. Kennedy, Jr.is under constant siege. The political establishment that has ...

When Dr Iona Weir, a cellular biologist, went in for a birth-repair surgery in 2008, she never countenanced the impact it ...

Alectinib showed a 22% reduction in death risk compared to crizotinib in advanced ALK-positive NSCLC, with a median OS of 81.1 months versus 54.2 months. Significant OS benefits were observed in ...

Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people living with rare diseases, and Protalix BioTherapeutics, Inc.

Health officials say the best way to prevent death or hospitalizations from the flu and other respiratory viruses is to get ...

The country’s new “Active Investor Plus” visa offers high-end investors several paths to permanent residency and runs against ...

Detailed price information for Wabash National Corp (WNC-N) from The Globe and Mail including charting and trades.

US stocks turned higher after President Trump said high tariffs on China will not stay. This helped markets recover from ...

Trump and EMD Serono strike a deal to cut fertility drug costs, expand U.S. manufacturing, and launch the TrumpRx Fertility ...